Literature DB >> 1623598

Serum adenosine deaminase: isoenzymes and diagnostic application.

J P Ungerer1, H M Oosthuizen, S H Bissbort, W J Vermaak.   

Abstract

Human adenosine deaminase (ADA; EC 3.5.4.4) consists of three isoenzymes: ADA1, ADA1+CP, and ADA2. We developed an electrophoretic technique to distinguish between these three isoenzymes. The isoenzyme pattern was studied in tissue and cell homogenates, as well as in serum from normal subjects and from patients with increased serum ADA who had either hepatitis, infectious mononucleosis, tuberculosis, pneumonia, rheumatoid arthritis, or acute lymphoblastic leukemia (ALL). The highest ADA activity was found in lymphocytes and monocytes. ADA2 could be detected only in monocytes (18% of total ADA activity). It was also the predominant isoenzyme in the sera of controls and all disease groups, except for ALL--the only condition evaluated that is not of an inflammatory nature. We conclude that serum ADA reflects monocyte/macrophage activity or turnover in most diseases studied. The exception is ALL, where serum ADA most probably originates from lymphocyte precursors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623598

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  37 in total

1.  Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii.

Authors:  Verônica S P Castro; Victor C Pimentel; Aleksandro S Da Silva; Gustavo R Thomé; Patrícia Wolkmer; Jorge L C Castro; Márcio M Costa; Cássia B da Silva; Daniele C Oliveira; Sydney H Alves; Maria R C Schetinger; Sonia T A Lopes; Cinthia M Mazzanti
Journal:  Mycopathologia       Date:  2011-12-15       Impact factor: 2.574

2.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Neuroinflammation after neonatal hypoxia-ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult.

Authors:  Victor Camera Pimentel; Maria Beatriz Moretto; Mariana Colino Oliveira; Daniela Zanini; Ana Maria Sebastião; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-02-27       Impact factor: 3.396

4.  A study on the status of inflammatory systems in camels naturally infected with Toxoplasma gondii.

Authors:  Fatemeh Azma; Seyed Mostafa Razavi; Saeed Nazifi; Ehsan Rakhshandehroo; Ahmad Reza Sanati
Journal:  Trop Anim Health Prod       Date:  2015-04-07       Impact factor: 1.559

5.  Structural basis for the growth factor activity of human adenosine deaminase ADA2.

Authors:  Anton V Zavialov; Xiaodi Yu; Dorothe Spillmann; Grégoire Lauvau; Andrey V Zavialov
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

6.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

7.  Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.

Authors:  Mustafa Calis; Filiz Ates; Cevat Yazici; Kader Kose; Mehmet Kirnap; Meltem Demir; Murat Borlu; Cem Evereklioglu
Journal:  Rheumatol Int       Date:  2005-05-03       Impact factor: 2.631

8.  Significance of cerebrospinal fluid adenosine deaminase isoenzymes in tuberculous (TB) meningitis.

Authors:  C M Schutte; J P Ungerer; H du Plessis; C H van der Meyden
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

9.  Adenosine deaminase isoenzymes in typhoid fever.

Authors:  J P Ungerer; H M Burger; S H Bissbort; W J Vermaak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

10.  Determination of adenosine deaminase activity in cattle naturally infected with Theileria annulata.

Authors:  Nuri Altuğ; Nazmi Yüksek; Zahid Tevfik Ağaoğlu; Ihsan Keleş
Journal:  Trop Anim Health Prod       Date:  2007-12-15       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.